Showing results (221-230 of 241) with videos related to

Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysisJ T Hartmann, L Einhorn, C R Nichols, et al.
Blood Cancer Journal|April 9, 2016
Carfilzomib alters the HLA-presented peptidome of myeloma cells and impairs presentation of peptides with aromatic C-terminiD J Kowalewski, S Walz, L Backert, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2003
Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell supportC Kollmannsberger, N Schleucher, O Rick, et al.
Journal of the National Cancer Institute|November 22, 2001
Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumorsJ T Hartmann, S D Fossa, C R Nichols, et al.
Bone Marrow Transplantation|October 6, 2015
Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomesR Vrhovac, M Labopin, F Ciceri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2003
Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study GroupH-J Schmoll, C Kollmannsberger, B Metzner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 28, 2005
Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACOC Kollmannsberger, W Budach, M Stahl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II studyW Brugger, J Hirsch, F Grünebach, et al.
Nature Medicine|March 4, 2000
Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybridsA Kugler, G Stuhler, P Walden, et al.
Blood|July 1, 1997
Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinaseI Rappold, B L Ziegler, I Köhler, et al.
Pageof 25